Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01234402 |
|---|---|
| Brief Title: | Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients |
| First Submitted : | November 3, 2010 |
| First Submitted that Met QC Criteria : | November 3, 2010 |
| First Posted : | November 4, 2010 (Estimate) |
| Results First Submitted : | June 13, 2019 |
| Results First Submitted that Met QC Criteria : | July 21, 2019 |
| Results First Posted : | August 14, 2019 |
| Certification/Extension First Submitted : | September 29, 2014 |
| Certification/Extension First Submitted that Met QC Criteria : | September 29, 2014 |
| Certification/Extension First Posted : | October 8, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 21, 2019 |
| Last Update Posted : | August 14, 2019 |